Fidia Advances Reserved Convertible Bond Plan with New Tranche and Share Conversion

Fidia Spa ( (IT:FDA) ) just unveiled an update.

Fidia S.p.A., based in Turin and listed on Euronext Milan, is among the world’s leading providers of numerical control technology and high-performance integrated milling systems, serving primarily the automotive mould and aerospace sectors. With over 50 years of experience and around 135 employees, it offers an integrated suite of numerical controls, high-speed milling machines and CAM software that covers the full milling workflow for complex shapes.

Fidia announced that Global Growth Holding Limited has subscribed to and paid for the fifth tranche of its 2026 reserved convertible bond loan with warrants, issuing 25 new bonds for a nominal €250,000 and 8,333,333 attached warrants exercisable at €0.03 per share. In parallel, GGHL converted one bond from the fourth tranche into 1,000,000 new shares at €0.01 per share, bringing total POC subscriptions to €1.25 million, partially increasing share capital and shares outstanding and signalling continued external financing and gradual dilution as the company strengthens its capital structure.

Following these transactions, Fidia’s share capital rises to €10,837,761.90 and the total number of shares to 58,542,927, while 26 subscribed bonds under the fourth and fifth tranches remain outstanding and not yet converted. The accumulation of unlisted warrants and remaining convertible bonds underscores an ongoing phase of capital raising with potential future equity issuance that existing shareholders and market participants will need to monitor for its impact on ownership and valuation.

The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.

More about Fidia Spa

Fidia S.p.A., based in Turin and listed on Euronext Milan, is among the world’s leading providers of numerical control technology and high-performance integrated milling systems. With more than 50 years of experience and around 135 employees, the group focuses on the mould segment for the automotive industry and on aerospace applications, offering numerical controls, high-speed milling systems and CAM software for complex shapes.

The company differentiates itself as one of the few industrial players able to cover the entire milling process, from defining machining programs through to the finished product. Its global sales and service footprint supports customers that require precision, speed and integrated solutions in demanding industrial sectors.

Average Trading Volume: 1,564,170

Technical Sentiment Signal: Strong Sell

Current Market Cap: €511.9K

For an in-depth examination of FDA stock, go to TipRanks’ Overview page.